# Topical Dermatologic Corticosteroids: in Vivo Bioequivalence - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/topical-dermatologic-corticosteroids-in-vivo-bioequivalence/7ffc2692-ebeb-401d-92f6-3b735fadd8d6

> FDA guidance document: Topical Dermatologic Corticosteroids: in Vivo Bioequivalence. Issue date: June 02, 1995. Get complete insights and analysis.

---

## Details

- Title: Topical Dermatologic Corticosteroids: in Vivo Bioequivalence
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 1995-06-02
- Last Changed: 2021-04-13
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2021-D-0384">FDA-2021-D-0384</a>

## Related Documents

- [Format and Content of the Human Pharmacokinetics and Bioavailability Section of an Application](https://www.globalkeysolutions.net/guidances/guidance-document/format-and-content-of-the-human-pharmacokinetics-and-bioavailability-section-of-an-application/0fc0547b-5081-4033-af56-10b885a39a8f)
- [Study of Drugs Likely to be used in the Elderly](https://www.globalkeysolutions.net/guidances/guidance-document/study-of-drugs-likely-to-be-used-in-the-elderly/00cfcd92-8ac1-4307-968b-117b25f0493c)
- [Format and Content of the Nonclinical Pharmacology/Toxicology Section of an Application*:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/format-and-content-of-the-nonclinical-pharmacologytoxicology-section-of-an-application-guidance-for-industry/4c2b4b0e-2182-43a9-b9b0-c3c92aee26b9)